Drw Securities, L.L.C. Repligen Corp Transaction History
Drw Securities, L.L.C.
- $4.72 Billion
- Q3 2022
A detailed history of Drw Securities, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Drw Securities, L.L.C. holds 10,600 shares of RGEN stock, worth $1.58 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,600Holding current value
$1.58 Million% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
504Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.13 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$982 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$755 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$285 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.25B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....